These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 22265638

  • 1. The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients.
    Namazi S, Kojuri J, Khalili A, Azarpira N.
    Biochem Pharmacol; 2012 Apr 01; 83(7):903-8. PubMed ID: 22265638
    [Abstract] [Full Text] [Related]

  • 2. The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.
    Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, Scott D, Gunes A, Dahl ML.
    JACC Cardiovasc Interv; 2008 Dec 01; 1(6):620-7. PubMed ID: 19463375
    [Abstract] [Full Text] [Related]

  • 3. Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
    Kim IS, Jeong YH, Park Y, Yoon SE, Kwon TJ, Park JR, Hwang SJ, Koh EH, Kwak CH, Hwang JY, Kim S.
    Br J Clin Pharmacol; 2012 Apr 01; 73(4):629-40. PubMed ID: 22007612
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G.
    JACC Cardiovasc Interv; 2013 Nov 01; 6(11):1166-75. PubMed ID: 24262617
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Polymorphisms of MDR1, CYP2C19 and P2Y12 genes in Indian population: effects on clopidogrel response.
    Shalia KK, Shah VK, Pawar P, Divekar SS, Payannavar S.
    Indian Heart J; 2013 Nov 01; 65(2):158-67. PubMed ID: 23647895
    [Abstract] [Full Text] [Related]

  • 9. Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation.
    Harmsze A, van Werkum JW, Bouman HJ, Ruven HJ, Breet NJ, Ten Berg JM, Hackeng CM, Tjoeng MM, Klungel OH, de Boer A, Deneer VH.
    Pharmacogenet Genomics; 2010 Jan 01; 20(1):18-25. PubMed ID: 19934793
    [Abstract] [Full Text] [Related]

  • 10. Effects of coexisting polymorphisms of CYP2C19 and P2Y12 on clopidogrel responsiveness and clinical outcome in patients with acute coronary syndromes undergoing stent-based coronary intervention.
    Tang XF, Zhang JH, Wang J, Han YL, Xu B, Qiao SB, Wu YJ, Chen J, Wu Y, Chen JL, Gao RL, Yang YJ, Yuan JQ.
    Chin Med J (Engl); 2013 Mar 01; 126(6):1069-75. PubMed ID: 23506580
    [Abstract] [Full Text] [Related]

  • 11. The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients.
    Gurbel PA, Bliden KP, Antonino MJ, Stephens G, Gretler DD, Jurek MM, Pakyz RE, Shuldiner AR, Conley PB, Tantry US.
    J Thromb Haemost; 2010 Jan 01; 8(1):43-53. PubMed ID: 19817997
    [Abstract] [Full Text] [Related]

  • 12. Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement.
    Hochholzer W, Trenk D, Fromm MF, Valina CM, Stratz C, Bestehorn HP, Büttner HJ, Neumann FJ.
    J Am Coll Cardiol; 2010 Jun 01; 55(22):2427-34. PubMed ID: 20510210
    [Abstract] [Full Text] [Related]

  • 13. Genetic determinants of response to clopidogrel and cardiovascular events.
    Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L, French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators.
    N Engl J Med; 2009 Jan 22; 360(4):363-75. PubMed ID: 19106083
    [Abstract] [Full Text] [Related]

  • 14. Diversity of platelet function and genetic polymorphism in clopidogrel-treated Chinese patients.
    Sun B, Li J, Dong M, Yang L, Wu C, Zhu L, Cong YL.
    Genet Mol Res; 2015 Feb 13; 14(1):1434-42. PubMed ID: 25730082
    [Abstract] [Full Text] [Related]

  • 15. Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study.
    Siller-Matula JM, Delle-Karth G, Lang IM, Neunteufl T, Kozinski M, Kubica J, Maurer G, Linkowska K, Grzybowski T, Huber K, Jilma B.
    J Thromb Haemost; 2012 Apr 13; 10(4):529-42. PubMed ID: 22260716
    [Abstract] [Full Text] [Related]

  • 16. The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.
    Saydam F, Değirmenci İ, Birdane A, Özdemir M, Ulus T, Özbayer C, Çolak E, Ata N, Güneş HV.
    Basic Clin Pharmacol Toxicol; 2017 Jul 13; 121(1):29-36. PubMed ID: 28135763
    [Abstract] [Full Text] [Related]

  • 17. Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.
    Hokimoto S, Chitose T, Mizobe M, Akasaka T, Arima Y, Kaikita K, Iwashita S, Morita K, Miyazaki H, Oniki K, Matsui K, Nakagawa K, Ogawa H.
    Eur J Clin Pharmacol; 2014 Jun 13; 70(6):667-73. PubMed ID: 24763934
    [Abstract] [Full Text] [Related]

  • 18. Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance.
    Siasos G, Oikonomou E, Vavuranakis M, Kokkou E, Mourouzis K, Tsalamandris S, Zaromitidou M, Kioufis S, Tsigkou V, Deftereos S, Stefanadis C, Tousoulis D.
    Cardiology; 2017 Jun 13; 137(2):104-113. PubMed ID: 28329746
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of CYP2C19, P2Y12, and ABCB1 polymorphisms and phenotypic response to clopidogrel in healthy Indian adults.
    Sridharan K, Kataria R, Tolani D, Bendkhale S, Gogtay NJ, Thatte UM.
    Indian J Pharmacol; 2016 Jun 13; 48(4):350-354. PubMed ID: 27756942
    [Abstract] [Full Text] [Related]

  • 20. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
    Kar R, Meena A, Yadav BK, Yadav R, Kar SS, Saxena R.
    Platelets; 2013 Jun 13; 24(4):297-302. PubMed ID: 22721490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.